Htg molecular diagnostics, inc (HTGM)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Operating activities
Net loss

-19,384

-19,297

-17,036

-17,139

-16,444

-16,453

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-24,829

-26,039

-26,066

-24,735

-24,336

-21,397

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,298

1,259

1,262

1,293

1,420

1,468

1,474

1,432

1,302

1,241

1,280

1,332

1,412

1,473

1,275

1,091

868

662

0

0

0

Accretion of discount on NuvoGen obligation

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of discount on NuvoGen obligation

-

-

-

-

-

-

-

89

142

195

198

201

205

206

0

0

0

-

-

-

-

Accretion of discount on NuvoGen obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Bad debt expense, net of recoveries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44

0

0

0

Provision for excess inventory

136

153

145

104

96

83

128

146

185

366

587

817

885

723

394

169

239

230

0

0

0

Amortization of Growth Term Loan discount and issuance costs

-

-

-

-

-

62

141

236

344

404

461

515

570

551

0

0

0

-

-

-

-

Loss on extinguishment of Growth Term Loan

-

-

-

-

-

-105

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of QNAH Convertible Note issuance costs

13

13

13

13

13

13

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of MidCap Credit Facility discount and issuance costs

186

183

170

166

170

133

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of discount on term loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of final payment premium on term loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of discount on convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Stock-based compensation expense

1,330

1,156

1,089

1,031

985

1,888

1,848

1,947

2,123

1,376

1,523

1,396

1,130

903

733

581

498

405

0

0

0

Employee stock purchase plan expense

54

66

64

63

61

58

58

58

58

59

0

0

0

-

-

-

-

-

-

-

-

Amortization of operating lease right-of-use assets

555

476

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of incentive from landlord

-

-

-

-

-

142

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in redeemable convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

239

0

0

0

Amortization of convertible note financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Accretion of incentive from landlord

-

-

-

-

-

-

-

-

-

142

142

142

142

130

0

0

0

-

-

-

-

Accrued interest on available-for-sale securities investments

327

325

351

402

418

412

0

0

0

-

-47

-52

-173

-172

0

0

0

-

-

-

-

Loss on abandonment of assets

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

-2,147

-1,848

583

510

357

-1,332

202

1,931

1,808

4,978

2,567

-360

621

661

-104

1,368

-216

-40

0

0

0

Inventory

595

116

208

262

195

171

-88

-288

-141

-77

-85

-108

-225

33

-3

-29

509

746

0

0

0

Prepaid expenses and other

47

177

251

212

82

113

154

370

90

3

86

-205

42

-11

-175

-93

204

334

0

0

0

Deferred offering costs

0

-

-

-

-

-2

-2

-2

-41

-49

0

0

0

-

-

-

-

-

-

-

-

Accounts payable

-86

-155

901

1,679

-552

-150

-418

89

836

1,225

1,163

-309

-393

10

309

487

471

-312

0

0

0

Accrued liabilities

-131

-1,440

-758

-913

-359

-447

533

1,214

399

2,076

705

-294

268

119

244

831

-177

455

0

0

0

Contract liabilities

224

188

175

306

-249

-426

-563

-311

216

355

0

0

0

-

-

-

-

-

-

-

-

Operating lease liabilities

-703

-632

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-15,033

-16,695

-15,414

-14,934

-16,065

-13,173

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Investing activities
Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

259

250

154

-6

6

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-20,746

-22,234

-21,869

-21,977

-20,951

-19,243

0

0

0

Purchase of property and equipment

1,025

1,103

845

439

595

949

1,352

1,697

1,412

1,020

612

477

1,791

1,946

2,247

2,514

1,214

1,338

0

0

0

Sales, redemptions and maturities of available-for-sale securities

27,650

32,200

0

0

0

-

-

-

-

4,300

11,050

15,350

28,450

29,750

0

0

0

-

-

-

-

Purchase of available-for-sale securities

30,773

34,601

21,764

25,181

37,000

53,970

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

-4,149

-3,504

24,090

25,178

6,904

-23,220

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Financing activities
Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

23,277

24,422

22,998

14,835

-29,061

-32,184

0

0

0

Proceeds from MidCap Credit Facility

-

-

-

-

-

7,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

MidCap Credit Facility lender fees

-

-

-

-

-

422

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

QNAH Convertible Note financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

75

0

0

0

Proceeds from Growth Term Loan

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

0

0

0

-

-

-

-

Payments on Growth Term Loan

-

-

-

-

-

1,684

3,333

4,947

6,527

6,389

0

0

0

-

-

-

-

-

-

-

-

Payments for extinguishment of Growth Term Loan

-

-

-

-

-

4,276

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from 2018 underwritten public offering, net of underwriting discounts, commissions and issuance costs of $2.6 million

-

-

-

-

-

37,724

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Public offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,002

0

0

0

Proceeds from ATM Offering, net

0

-

-

-

-

556

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Series A convertible preferred stock in private placement

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of pre-funded warrants

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8

0

0

0

Payments on NuvoGen obligation

1,152

1,327

1,286

1,232

1,290

1,012

929

835

785

800

0

0

0

-

-

-

-

-

-

-

-

Payments on financing leases

42

44

37

47

55

62

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital leases

-

-

-

-

-

-

-

-

-

69

77

91

132

133

107

81

49

29

0

0

0

Proceeds from exercise of stock options

-

120

233

368

327

316

151

71

117

112

0

0

0

-

-

-

-

34

0

0

0

Taxes paid for net share settlement of restricted stock awards

-28

-30

-45

-38

-26

-150

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible note warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

0

Payment of deferred offering costs

-

190

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

22,618

19,391

19,977

-928

-1,127

38,129

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rates on cash

-7

-4

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash, cash equivalents and restricted cash

3,428

-812

28,683

9,309

-10,285

1,734

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-4,685

2,025

1,796

3,482

53,372

51,108

0

0

0

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-2,154

4,213

2,925

-3,660

3,358

-319

0

0

0

Supplemental disclosure of noncash investing and financing activities
Fixed asset purchases payable and accrued at period end

284

8

31

410

49

39

97

408

437

477

411

-115

-959

26

0

0

0

-

-

-

-

Adoption of ASC 842, Leases

-

694

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs payable and accrued at period end

-

-

-

-

0

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Allocation of term loan B warrant discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Accretion of preferred stock issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35

0

0

0

Accretion of dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,165

0

0

0

Accrual of deferred offering and finance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Allocation of Series E warrant convertible notes debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

741

0

0

0

Issuance of Series A convertible preferred stock in exchange for outstanding common stock

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series A convertible preferred stock in private placement, costs payable and accrued at period end

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock in connection with LP Purchase Agreement

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

LP Purchase Agreement, costs payable and accrued at period end

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equipment purchased through capital leases

-

-

-

-

-

71

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Debt issuance costs payable and accrued at period end

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

MidCap Term Loan fees and warrant discount

-

-

-

-

-

389

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued for settlement of accrued bonus

-

-

-

-

-

-

-

-

-

-

-

-

-

364

0

0

0

-

-

-

-

Purchase of property and equipment under capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

227

0

0

0

-

-

-

-

Incentive from landlord

-

-

-

-

-

-

-

-

-

-

-

-

-

710

0

0

0

-

-

-

-

Retirement of treasury stock

-

-

-

-

-

-

-

-

-

75

0

0

0

-

-

-

-

-

-

-

-

Supplemental cash flow information
Cash paid for interest

678

686

705

698

641

553

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

834

967

1,097

1,109

1,084

1,027

938

935

0

0

0

Cash paid for taxes

-

-

-

-

-

-

-

-

-

1

0

0

0

-

-

-

-

-

-

-

-